Clinical trial
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
NCT00003099 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003099 |
|---|---|
| Title | Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer |
| Official title | Phase II Clinical Trial of N-(4-hydroxyphenyl) Retinamide (4-HPR) and Tamoxifen in Breast Neoplasia, Administration During the Period Between the Diagnostic Core Biopsy and Definitive Surgery |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | Fenretinide, Tamoxifen Citrate, Placebo |
| Enrollment | 52 |
| Start date | May 1, 1996 |
| Primary completion | Jun 1, 2000 |
| Completion | Jan 1, 2003 |
| First posted | Jun 16, 2004 |
| Last update posted | Jul 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: